液体 vs 固体培养基评估结核病疑似患者管理变更比例与时间:巴西二三级医疗机构的实用性随机试验

巴西实用性随机试验数据,比较液体与固体培养基在结核病诊断中的效果,主要指标为2个月内治疗变更比例。

Figshare
2016-01-15 更新
浏览 17
表格isrctnBrazil BackgroundThe useLJ grouphealth care unitrrTertiary Health Care Unitsnntcase management modelmdMGIT 960 systemcitb
Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis—A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil

基本信息

模态
表格
大小
0.000682634 GB
许可
CC BY 4.0
创建/更新时间
2016-01-15
版本
v1

资源简介

液体 vs 固体培养基评估结核病疑似患者管理变更比例与时间:巴西二三级医疗机构的实用性随机试验

【数据集背景】

本数据集源站标题为《Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis—A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil》。配套论文《Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis—A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil》发表于 PLOS ONE(2015),DOI:10.1371/journal.pone.0127588。源站首次发布:2015-06-05。

【数据内容】

源站原始描述:Background The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes. Methods and Findings A pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analys…

【数据结构与技术规格】

文件数 4 个,合计 682.63 KB。S1_Fig.pdf:application/pdf,125.42 KB。S1_Text.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,38.56 KB。S2_Text.doc:application/msword,295.94 KB。数据集 DOI:10.1371/journal.pone.0127588。

【主题与分类】

源站学科分类:Biological Sciences。主题标签:isrctn、Brazil BackgroundThe use、LJ group、health care unit、rr、Tertiary Health Care Units、nnt、case management model、md、MGIT 960 system。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Liquid_vs_Solid_Culture_Medium_to_Evaluate_Proportion_and_Time_to_Change_in_Management_of_Suspects_of_Tuberculosis_A_Pragmatic_Randomized_Trial_in_Secondary_and_Tertiary_Health_Care_Units_in_Brazil/1438797

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:da Silva Rezende Moreira, Adriana; Huf, Gisele; Armanda Monteiro da Silva Vieira, Maria; Albuquerque da Costa, Paulo; Aguiar, Fábio; Grazia Marsico, Anna; et al. (2016). Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis—A Pragmatic Ran…

【使用注意】

· 源站最后修改于 2023-05-31,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "S1_Fig.pdf" "https://ndownloader.figshare.com/files/2098352"
curl -L -o "S1_Text.docx" "https://ndownloader.figshare.com/files/2098353"
curl -L -o "S2_Text.doc" "https://ndownloader.figshare.com/files/2098354"
curl -L -o "S3_Text.doc" "https://ndownloader.figshare.com/files/2098355"

文件清单

  • S1_Fig.pdf(125.42 KB)
  • S1_Text.docx(38.56 KB)
  • S2_Text.doc(295.94 KB)
  • S3_Text.doc(222.72 KB)

文件总体积 682.63 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes.
Methods and Findings
A pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analysis. MGIT960 technique was compared with the Lowenstein-Jensen (LJ) method for laboratory diagnosis of active TB. Primary outcome was the proportion of patients who had their initial medical management changed within 2 months after randomisation. Secondary outcomes were: mean time for changing the procedure, patient satisfaction with the overall treatment and adverse events. Data were analysed by intention-to-treat. Between April 2008 and September 2011, 693 patients were enrolled (348 to MGIT, 345 to LJ). Smear and culture results were positive for 10% and 15.7% of participants, respectively. Patients in the MGIT arm had their initial medical management changed more frequently than those in the LJ group (10.1% MGIT vs 3.8% LJ, RR 2.67 95% CI 1.44–.96, p = 0.002, NNT 16, 95% CI 10–39). Mean time for changing the initial procedure was greater in LJ group at both sites: 20.0 and 29.6 days in MGIT group and 52.2 and 64.3 in LJ group (MD 33.5, 95% CI 30.6–36.4, p = 0.0001). No other important differences were observed.
Conclusions
This study suggests that opting for the MGIT960 system for TB diagnosis provides a promising case management model for improving the quality of care and control of TB.
Trial Registration
Controlled-Trials.com ISRCTN79888843

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0127588(source: https://plos.figshare.com/articles/dataset/Liquid_vs_Solid_Culture_Medium_to_Evaluate_Proportion_and_Time_to_Change_in_Management_of_Suspects_of_Tuberculosis_A_Pragmatic_Randomized_Trial_in_Secondary_and_Tertiary_Health_Care_Units_in_Brazil/1438797)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案